AI-based biomarker for aortic stenosis found by Yale researchers
A deep learning model built by Yale investigators analyzes video of cardiac ultrasound to identify those who might experience thickening of the aortic valve. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 11, 2024 Category: Universities & Medical Training Source Type: news

AI-based tool uncovers hidden signatures of aortic stenosis
A deep learning model built by Yale investigators analyzes video of cardiac ultrasound to identify those who might experience thickening of the aortic valve. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 11, 2024 Category: Universities & Medical Training Source Type: news

ACC: AI-Based Video Biomarker Detects Aortic Stenosis Progression
MONDAY, April 8, 2024 -- A video-based artificial intelligence (AI) biomarker (Digital Aortic Stenosis [AS] Severity index [DASSi]) can detect severe AS development and progression among patients undergoing echocardiography or cardiac magnetic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news

ARBs May Slow Fibrosis in Female Aortic Stenosis Patients ARBs May Slow Fibrosis in Female Aortic Stenosis Patients
A retrospective study found a sex difference in patients with aortic stenosis treated with ARBs.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 8, 2024 Category: Cardiology Tags: Cardiology Source Type: news

Novel Biomarkers for Aortic Stenosis Identified Novel Biomarkers for Aortic Stenosis Identified
Using plasma proteomics and other approaches, researchers detected circulating proteins robustly associated with AV hemodynamics and the risk for related hospitalization.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2024 Category: Consumer Health News Tags: Cardiology Source Type: news

iCardio.ai launches apps on Butterfly Garden
Los Angeles-based startup iCardio.ai has joined Butterfly Network’s recently launched AI marketplace, Butterfly Garden. Under the terms of the agreement, iCardio.ai will deploy a suite of cardiac ultrasound AI tools in Butterfly Garden that use Butterfly’s handheld, whole-body point-of-care ultrasound (POCUS) probe. For instance, the suite features automation of preliminary echocardiographic reports of key measurements of the heart that can help detect valvular diseases, like aortic stenosis, and provide image quality assessments, Butterfly said.Butterfly launched Butterfly Garden in August to facilitate partnerships w...
Source: AuntMinnie.com Headlines - November 15, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Five-Year Outcomes Similar With TAVR, Surgery in Low-Risk Patients
THURSDAY, Nov. 2, 2023 -- For patients with severe, symptomatic aortic stenosis at low surgical risk, five-year outcomes are similar with transcatheter aortic-valve replacement (TAVR) versus surgical aortic valve replacement, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2023 Category: Pharmaceuticals Source Type: news

TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus
FRIDAY, Oct. 27, 2023 -- For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 27, 2023 Category: Pharmaceuticals Source Type: news

Small Aortic Annuli Not Inherently More Amenable to TAVR
(MedPage Today) -- SAN FRANCISCO -- One anatomic feature, typically found in women, did not make patients with severe aortic stenosis (AS) better suited for either transcatheter aortic valve replacement (TAVR) or surgery, the VIVA trial investigators... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2023 Category: Cardiology Source Type: news

TAVR With LAAO Non-inferior to TAVR Plus Medical Therapy TAVR With LAAO Non-inferior to TAVR Plus Medical Therapy
Left atrial appendage occlusion in the same procedure with transcatheter aortic valve replacement proved non-inferior to TAVR plus medical therapy in AF and aortic stenosis, in the WATCH-TAVR study.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 25, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news

Combining TAVR, LAA Closure in Same Procedure Safe, Trial Says
(MedPage Today) -- SAN FRANCISCO -- Left atrial appendage occlusion (LAAO) at the time of transcatheter aortic valve replacement (TAVR) appeared as safe as TAVR alone, the WATCH-TAVR trial showed. For patients with severe aortic stenosis and... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news

Medtronic's Evolut FX TAVI System Gets CE Mark
Medtronic today announced that its latest iteration of the Evolut TAVI/TAVR system, the Evolut ™ FX, has received the CE (Conformité Européenne) Mark. Although medical devices often are approved in Europe prior to US approval, the Evolut FX did the opposite: it garnered US FDA approval two years ago. Today's announcement means that this newest and most advanced transcatheter platform for treating severe aortic stenosis will now be available in Europe and beyond. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 13, 2023 Category: Cardiology Source Type: news

Mayo Clinic researchers develop calculation to identify high-risk moderate aortic stenosis patients
ROCHESTER, Minn. — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis patients at higher risk of dying from the condition. According to new research published in Mayo Clinic Proceedings, calculating the patient's mean arterial pressure (AugMAP) is a simple and effe ctive way to identify those patients who may benefit from more aggressive treatment strategies. "Physiologically, AugMAP can be considered a marker of global left ventricular contractile function," says Chieh-Ju… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 4, 2023 Category: Databases & Libraries Source Type: news

Reassuring Registry Data on Going Into TAVR Sans Symptoms
(MedPage Today) -- Transcatheter aortic valve replacement (TAVR) got some preliminary affirmation for asymptomatic or minimally symptomatic severe aortic stenosis in a retrospective registry study. Of participants who got elective TAVR, the one... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 21, 2023 Category: Cardiology Source Type: news

Artificial Intelligence automates diagnosis of severe heart valve disease
A Yale research team has developed a new approach to detect a common valvular heart disease known as severe aortic stenosis from ultrasound scans of the heart. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 24, 2023 Category: Universities & Medical Training Source Type: news